Lichen China Limited Class A Ordinary Shares Cash Flow Conversion Efficiency
Lichen China Limited Class A Ordinary Shares cash flow conversion efficiency. Based on the latest financial reports, Lichen China Limited Class A Ordinary Shares (LICN) has a cash flow conversion efficiency ratio of -0.227x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-15.99 Million) by net assets ($70.55 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Lichen China Limited Class A Ordinary Shares (2014–2025)
Cash flow conversion efficiency of Lichen China Limited Class A Ordinary Shares from 2014 to 2025. This chart illustrates how Lichen China Limited Class A Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Lichen China Limited Class A Ordinary Sh (LICN) stock price for real-time trading data and today's change.
Lichen China Limited Class A Ordinary Shares Cash Flow Conversion Ratio Explained
Lichen China Limited Class A Ordinary Shares cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Lichen China Limited Class A Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lichen China Limited Class A Ordinary Shares ranked by their cash flow conversion efficiency. Also see Lichen China Limited Class A Ordinary Sh (LICN) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pertama Digital Berhad
KLSE:8532
|
-0.001x |
|
Sanko Diecasting (Thailand) Public Company Limited
BK:SANKO
|
0.092x |
|
Precise Biometrics AB
ST:PREC
|
0.029x |
|
MITCON Consultancy & Engineering Services Limited
NSE:MITCON
|
0.147x |
|
Panda Financial Holding Corp Ltd
SHG:600599
|
0.403x |
|
Active Biotech AB
ST:ACTI
|
-0.242x |
|
TME PHARM.CONF.IPO EO 1-
F:0N6A
|
N/A |
|
Txcom SA
PA:ALTXC
|
-0.023x |
Annual Cash Flow Conversion Efficiency for Lichen China Limited Class A Ordinary Shares (2014–2025)
The table below shows the annual cash flow conversion efficiency of Lichen China Limited Class A Ordinary Shares from 2014 to 2025. Review LICN cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $70.55 Million | $-17.85 Million | -0.253x | -243.10% |
| 2024-12-31 | $75.56 Million | $-5.57 Million | -0.074x | -913.10% |
| 2023-12-31 | $61.42 Million | $557.00K | 0.009x | -96.54% |
| 2022-12-31 | $41.11 Million | $10.77 Million | 0.262x | +32.06% |
| 2021-12-31 | $36.83 Million | $7.30 Million | 0.198x | -34.35% |
| 2020-12-31 | $27.64 Million | $8.35 Million | 0.302x | -47.18% |
| 2019-12-31 | $23.73 Million | $13.57 Million | 0.572x | +66.90% |
| 2017-12-31 | $18.57 Million | $6.36 Million | 0.343x | -57.54% |
| 2016-12-31 | $10.90 Million | $8.80 Million | 0.807x | +82.26% |
| 2015-12-31 | $8.39 Million | $3.72 Million | 0.443x | +31.54% |
| 2014-12-31 | $3.74 Million | $1.26 Million | 0.337x | -- |
About Lichen China Limited Class A Ordinary Shares
Lichen International Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. The company offers financial and taxation-related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and edu… Read more